Biologic Therapy Does Not Increase Postoperative Complication in Crohn's Disease

被引：0
|
作者：
Alhamly, Hadeel Z. M.
Qadhi, Iman N.
Al-rubaiah, Rawan
Alabbad, Jasim Y.
Raheem, Fawaz Abdul
机构：
[1] Kuwait Inst Med Specializat, Kuwait, Kuwait
[2] Minist Hlth, Jabriya, Kuwait
[3] Kuwait Inst Med Specializat, Safat, Kuwait
[4] Minist Hlth, Al Asimah, Kuwait
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2023年 / 237卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [41] Brain Abscesses in Crohn's Disease as a Complication of Infliximab Therapy
    Mansour, Mahmoud M.
    Mubarak, Muhammad
    Chela, Harleen
    Ghouri, Yezaz A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [42] A Complication of Crohn's Disease?
    Jaswani, Tamika S.
    Hobson, Erin M.
    Grider, Douglas J.
    GASTROENTEROLOGY, 2019, 157 (01) : 31 - 33
  • [43] Biological therapy prior to repeat ileocolic resection in Crohn's disease can reduce the postoperative complication rate
    Horesh, N.
    Freund, M. R.
    Garoufalia, Z.
    Gefen, R.
    Zhang, D.
    Smith, T.
    Emile, S. H.
    Wexner, S. D.
    TECHNIQUES IN COLOPROCTOLOGY, 2023, 27 (04) : 291 - 296
  • [44] Biological therapy prior to repeat ileocolic resection in Crohn’s disease can reduce the postoperative complication rate
    N. Horesh
    M. R. Freund
    Z. Garoufalia
    R. Gefen
    D. Zhang
    T. Smith
    S. H. Emile
    S. D. Wexner
    Techniques in Coloproctology, 2023, 27 : 291 - 296
  • [45] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn's Disease
    Regueiro, Miguel
    El-Hachem, Sandra
    Kip, Kevin E.
    Schraut, Wolfgang
    Baidoo, Leonard
    Watson, Andrew
    Swoger, Jason
    Schwartz, Marc
    Barrie, Arthur
    Pesci, Marilyn
    Binion, David
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) : 3610 - 3615
  • [46] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease
    Miguel Regueiro
    Sandra El-Hachem
    Kevin E. Kip
    Wolfgang Schraut
    Leonard Baidoo
    Andrew Watson
    Jason Swoger
    Marc Schwartz
    Arthur Barrie
    Marilyn Pesci
    David Binion
    Digestive Diseases and Sciences, 2011, 56 : 3610 - 3615
  • [47] BIOLOGIC THERAPY AND SURGERY IN CROHN'S DISEASE: WHAT HAS CHANGED?
    Kayali, S.
    Gaiani, F.
    De' Angelis, N.
    Iuliano, S.
    Bizzarri, B.
    Ghiselli, A.
    Vincenzi, F.
    Nervi, G.
    Fornaroli, F.
    De' Angelis, G. L.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S131 - S131
  • [48] ECONOMIC BURDEN OF BIOLOGIC THERAPY FOR CHINESE PATIENTS WITH CROHN'S DISEASE
    Sheng, Y.
    Hu, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S114 - S115
  • [49] Safety of Biologic Therapy for Crohn's Disease: An Active Pharmacovigilance Study
    Ruffolo, L.
    Palleria, C.
    Citraro, R.
    Leo, A.
    Tallarico, M.
    Sarro, C. D.
    Leporini, C.
    Caccavo, I.
    Marciano, G.
    Vocca, C.
    Casarella, A.
    Spagnuolo, R.
    Doldo, P.
    Gallelli, L.
    Sarro, G. D.
    DRUG SAFETY, 2022, 45 (10) : 1154 - 1155
  • [50] Biologic therapy for Crohn's disease over the last 3 decades
    Ji-Liang Shen
    Zheng Zhou
    Jia-Sheng Cao
    Bin Zhang
    Jia-Hao Hu
    Jia-Ying Li
    Xiao-Ming Liu
    Sarun Juengpanich
    Ming-Song Li
    Xu Feng
    World Journal of Clinical Cases, 2022, 10 (02) : 594 - 606
12345